indirubin has been researched along with Cancer of Ovary in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, L; Hu, J; Wang, J; Wu, J; Zheng, Q | 1 |
Esteban Fernández, J; Fernández de Orueta, L; Martínez Carrilero, J; Melero Bermejo, JA; Pérez Caballero, G; Regajo Gallego, R | 1 |
2 other study(ies) available for indirubin and Cancer of Ovary
Article | Year |
---|---|
Indirubin suppresses ovarian cancer cell viabilities through the STAT3 signaling pathway.
Topics: Antibiotics, Antineoplastic; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Indoles; Ovarian Neoplasms; Signal Transduction; STAT3 Transcription Factor; Structure-Activity Relationship; Tumor Cells, Cultured | 2018 |
Purple urine.
Topics: Acute Kidney Injury; Adenocarcinoma; Aged; Biotransformation; Color; Female; Humans; Hydrogen-Ion Concentration; Indigo Carmine; Indoles; Klebsiella Infections; Klebsiella pneumoniae; Ovarian Neoplasms; Peritoneal Neoplasms; Proteus Infections; Proteus mirabilis; Tryptophan; Urinary Tract Infections; Urine | 2011 |